1. Home
  2. BELFA vs ADMA Comparison

BELFA vs ADMA Comparison

Compare BELFA & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bel Fuse Inc.

BELFA

Bel Fuse Inc.

HOLD

Current Price

$245.50

Market Cap

2.3B

Sector

N/A

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$11.00

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BELFA
ADMA
Founded
1949
2004
Country
United States
United States
Employees
4964
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.4B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
BELFA
ADMA
Price
$245.50
$11.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$174.25
$25.67
AVG Volume (30 Days)
76.5K
8.6M
Earning Date
04-29-2026
05-08-2026
Dividend Yield
0.10%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.60
Revenue
N/A
$42,219,783.00
Revenue This Year
$9.74
$27.46
Revenue Next Year
$6.34
$22.11
P/E Ratio
$40.02
$18.16
Revenue Growth
N/A
43.85
52 Week Low
$60.97
$7.21
52 Week High
$242.28
$25.67

Technical Indicators

Market Signals
Indicator
BELFA
ADMA
Relative Strength Index (RSI) 73.32 46.12
Support Level $114.22 $7.21
Resistance Level N/A $16.61
Average True Range (ATR) 8.34 0.48
MACD 3.42 0.35
Stochastic Oscillator 91.49 85.27

Price Performance

Historical Comparison
BELFA
ADMA

About BELFA Bel Fuse Inc.

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: